167 related articles for article (PubMed ID: 7911420)
21. Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field.
Dalm VA; Hofland LJ; Lamberts SW
Mol Cell Endocrinol; 2008 May; 286(1-2):262-77. PubMed ID: 17942217
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
van den Anker-Lugtenburg PJ; Krenning EP; Oei HY; Van Hagen MP; Gerrits CJ; Reubi JC; Lamberts SW; Löwenberg B
Br J Haematol; 1996 Apr; 93(1):96-103. PubMed ID: 8611482
[TBL] [Abstract][Full Text] [Related]
23. Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.
Ferone D; Pivonello R; Van Hagen PM; Dalm VA; Lichtenauer-Kaligis EG; Waaijers M; Van Koetsveld PM; Mooy DM; Colao A; Minuto F; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1056-66. PubMed ID: 12376335
[TBL] [Abstract][Full Text] [Related]
24. Lack of evidence for autocrine feedback regulation by somatostatin in somatostatin receptor-containing meningiomas.
Reubi JC; Mengod G; Palacios JM; Horisberger U; Hackeng WH; Lamberts SW
Cell Growth Differ; 1990 Jun; 1(6):299-303. PubMed ID: 1980601
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
[TBL] [Abstract][Full Text] [Related]
26. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptors and breast cancer.
van Eijck CH; Kwekkeboom DJ; Krenning EP
Q J Nucl Med; 1998 Mar; 42(1):18-25. PubMed ID: 9646641
[TBL] [Abstract][Full Text] [Related]
28. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver.
Slooter GD; Breeman WA; Marquet RL; Krenning EP; van Eijck CH
Int J Cancer; 1999 May; 81(5):767-71. PubMed ID: 10328231
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptor expression in clinical immunology.
van Hagen PM
Metabolism; 1996 Aug; 45(8 Suppl 1):86-7. PubMed ID: 8769392
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin actions via somatostatin receptors on the ocular surface are modulated by inflammatory processes.
Minsel I; Mentlein R; Sel S; Diebold Y; Bräuer L; Mühlbauer E; Paulsen FP
Endocrinology; 2009 May; 150(5):2254-63. PubMed ID: 19106227
[TBL] [Abstract][Full Text] [Related]
31. Novel subtype specific and universal somatostatin analogues: clinical potential and pitfalls.
van der Hoek J; Hofland LJ; Lamberts SW
Curr Pharm Des; 2005; 11(12):1573-92. PubMed ID: 15892663
[TBL] [Abstract][Full Text] [Related]
32. [Somatostatin receptors in non-endocrine tumours].
Casini Raggi C; Pinzani P; Gelmini S; Tricarico C; Orlando C; Calabrò A; Renzi D; Cianchi F; Valanzano R; Distante V; Cortesini C; Tonelli F; Cataliotti L; Cameron Smith M; Messerini L; Bianchi S; Pazzagli M; Serio M; Maggi M
Minerva Endocrinol; 2001 Sep; 26(3):149-58. PubMed ID: 11753238
[TBL] [Abstract][Full Text] [Related]
33. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
[TBL] [Abstract][Full Text] [Related]
34. Modulation of lymphocyte function by sensory neuropeptides.
Payan DG; Goetzl EJ
J Immunol; 1985 Aug; 135(2 Suppl):783s-786s. PubMed ID: 2409166
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease: more extended disease identified.
Lugtenburg PJ; Krenning EP; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Löwenberg B
Br J Haematol; 2001 Mar; 112(4):936-44. PubMed ID: 11298588
[TBL] [Abstract][Full Text] [Related]
36. Luteinizing hormone-releasing hormone (LHRH) receptors in the neuroendocrine-immune network. Biochemical bases and implications for reproductive physiopathology.
Marchetti B; Gallo F; Farinella Z; Romeo C; Morale MC
Ann N Y Acad Sci; 1996 Apr; 784():209-36. PubMed ID: 8651571
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptors in malignant lymphomas: targets for radiotherapy?
Dalm VA; Hofland LJ; Mooy CM; Waaijers MA; van Koetsveld PM; Langerak AW; Staal FT; van der Lely AJ; Lamberts SW; van Hagen MP
J Nucl Med; 2004 Jan; 45(1):8-16. PubMed ID: 14734660
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells.
Gu ZF; Corleto VD; Mantey SA; Coy DH; Maton PN; Jensi RT
Am J Physiol; 1995 May; 268(5 Pt 1):G739-48. PubMed ID: 7762657
[TBL] [Abstract][Full Text] [Related]
40. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
